US$ 28.66
sglt2 inhibitors and glp-1 receptor agonists together Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar GLP-1 receptor agonists and SGLT2
Description
Long-Term Safety: Although GLP-1 medications have demonstrated efficacy and safety in clinical trials, their long-term safety profile is still being evaluated

Regular physical activity, especially strength training, is also critical to helping slow the loss of muscle during weight-loss therapy

In a JAMA, researchers analyzed a wide population of people with type 2 diabetes and reported that GLP-1RA drugs do not increase the risk of pancreatic cancer compared to basal insulin over a 7-year period
Hepatology 2018;67:328-357

Mol Endocrinol 1989;3:101421.ArticlePubMed 18
